Abstract
A laboratory-confirmed lymphogranuloma venereum (LGV) case in Slovenia was reported in 2015, in a human immunodeficiency virus (HIV)-negative man presenting with inguinal lymphadenopathy. He reported unprotected insertive anal intercourse with two male partners in Croatia. Variant L2c of Chlamydia trachomatis was detected in clinical samples. Although the patient was eventually cured, the recommended treatment regimen with doxycycline had to be prolonged.
Highlights
Lymphogranuloma venereum is caused by CT strains of serovars L1, L2 and L3
It occurred in a HIV-negative men who have sex with men (MSM) who presented with inguinal lymphadenopathy and who was infected with CT genotype variant L2c
In 2013, information on HIV status was available for 520 LGV cases (50%) reported to ECDC, of whom 62% occurred in HIV-positive individuals and only 14% in HIV-negative [5]
Summary
Confirmed inguinal lymphogranuloma venereum genovar L2c in a man who had sex with men, Slovenia, 2015. A laboratory-confirmed lymphogranuloma venereum (LGV) case in Slovenia was reported in 2015, in a human immunodeficiency virus (HIV)-negative man presenting with inguinal lymphadenopathy. He reported unprotected insertive anal intercourse with two male partners in Croatia. We describe a laboratory-confirmed case of lymphogranuloma venereum (LGV) in Slovenia, reported to the National Institute of Public Health (NIPH) in 2015 according to the Communicable Diseases Act that provides for mandatory universal reporting of all diagnosed LGV cases
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
